MELYNDA MATHERLY: Open Payments
NPI 1295727592 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,060 in 134 payments from 18 companies in 2025. Trend: 2023 $3,080 · 2024 $3,214 · 2025 $3,060
Food & beverage: $2,951Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $544 |
| Janssen Biotech, Inc. | 15 | $494 |
| Regeneron Healthcare Solutions, Inc. | 14 | $460 |
| UCB, Inc. | 19 | $398 |
| Novartis Pharmaceuticals Corporation | 13 | $257 |
| Amgen Inc. | 10 | $171 |
| LEO Pharma Inc. | 9 | $171 |
| GENZYME CORPORATION | 5 | $138 |
| E.R. Squibb & Sons, L.L.C. | 4 | $97 |
| Galderma Laboratories, L.P. | 3 | $67 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, Otezla, ADBRY, RINVOQ.
Industry payments across KY — which companies pay providers there.
